ArticleLancet regional health. Americas2026
Doxy-PEP interest, awareness, and use among sexual and gender minorities in Brazil, Mexico, and Peru: findings from a web-based survey.
Article in Lancet regional health. Americas, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Mpox Vaccination and Diagnosis Among Sexual and Gender Diverse Populations in Brazil: Results From a Large Nationwide Online Survey.Journal of the International AIDS Society · 2026Article
- The intersection of sexually transmitted infections and antimicrobial stewardship: opportunities for synergy.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2026Article
- High burden of depressive symptoms among sexual and gender diverse persons in Brazil: The role of discrimination, internalized homonegativity, and race.PLOS global public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sexual and gender minorities (SGM) face a disproportionate burden of sexually transmitted infections (STIs) in Latin America. Doxycycline post-exposure prophylaxis (doxy-PEP) is effective in preventing syphilis, chlamydia and gonorrhea among these populations. We explored doxy-PEP awareness, interest and use in Brazil, Mexico and Peru. Methods: Cross-sectional online survey among SGM assigned male at birth (18+ years) recruited on dating apps (Scruff and Grindr) and social media (Instagram and Facebook). Adjusted logistic regression models were used to explore factors associated with doxy-PEP awareness overall and by country. Findings: Among 16,081 participants (Brazil: 10,269; Mexico: 4081; Peru: 1731), 16% reported previous STI diagnosis. Only 37.7% and 7.2% reported doxy-PEP awareness and use, but interest was high (88.3%). Age >30 years (adjusted odds ratio [aOR]:0.88 [95% confidence interval [CI]:0.79-0.98), post-secondary education (aOR: 1.21, 95% CI: 1.08-1.36), 5+ sex partners (aOR: 1.32, 95% CI: 1.20-1.46), stimulant use (aOR: 1.20, 95% CI: 1.07-1.35), ever PrEP use or living with HIV (aOR: 2.76, 95% CI: 2.49-3.06), higher HIV knowledge (aOR per one standard deviation [SD] increase: 1.35, 95% CI: 1.28-1.44), and higher internalized homonegativity (aOR per one SD increase: 0.87, 95% CI: 0.83-0.91) were associated with doxy-PEP awareness. Interpretation: Despite high interest in using doxy-PEP, its awareness and use remain limited among SGM in Latin America. Targeted efforts are crucial to raise awareness, especially among populations with lower education levels, limited HIV knowledge, and those less engaged with existing prevention services. Strengthening educational campaigns and integrating doxy-PEP into public health sexual health programs will be key to ensuring equitable access and reducing STI incidence. Funding: Unitaid, CNPq and FAPERJ.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.